Your browser doesn't support javascript.
loading
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients.
Balcar, Lorenz; Bauer, David; Pomej, Katharina; Meischl, Tobias; Mandorfer, Mattias; Reiberger, Thomas; Trauner, Michael; Scheiner, Bernhard; Pinter, Matthias.
Afiliação
  • Balcar L; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Bauer D; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
  • Pomej K; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Meischl T; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
  • Mandorfer M; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Reiberger T; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
  • Trauner M; Department of Internal Medicine III, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Scheiner B; Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
  • Pinter M; 3rd Medical Department (Hematology & Oncology), Hanusch Krankenhaus, Vienna, Austria.
PLoS One ; 18(4): e0282680, 2023.
Article em En | MEDLINE | ID: mdl-37027398

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria